Biological role of surface Toxoplasma gondii antigen in development of vaccine

doi:10.3748/wjg.v12.i15.2363

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2838)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

310

HTML

2386

Figures (1-6)

142

Sum=2838

Apr 21, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 21, 2006; 12(15): 2363-2368
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2363

Full Size Figure Download Figure

Figure 3 Antibody responses to r-SAG1. BALB/C mice were immunized with 30 µg r-SAG1 of T gondii or with PBS as a control. Booster was done with Freund’s incomplete adjuvant 2 wk after the first injection. Three weeks post-immunization, sera were collected from 5 mice of each group. Antibodies were tested individually by ELISA.

Citation: Liu KY, Zhang DB, Wei QK, Li J, Li GP, Yu JZ. Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol 2006; 12(15): 2363-2368
URL: https://www.wjgnet.com/1007-9327/full/v12/i15/2363.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i15.2363